Adequacy of Peripheral Blood Stem Cell Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine: A Pilot Project and a Proof of Concept Study

Trial Profile

Adequacy of Peripheral Blood Stem Cell Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine: A Pilot Project and a Proof of Concept Study

Completed
Phase of Trial: Phase 0

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Bendamustine (Primary) ; Rituximab
  • Indications Non-Hodgkin's lymphoma
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 12 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 31 Mar 2015 Planned End Date changed from 1 Jan 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
    • 05 Nov 2014 Planned End Date changed from 1 Sep 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top